Pfizer’s Phase 3 Xalkori NSCLC trial meets primary objective
18 November 2015 | By Victoria White
Xalkori demonstrated significantly prolonged progression-free survival in previously untreated East Asian patients with ALK-positive advanced NSCLC...
List view / Grid view
News
Portsmouth PMU selects Cherwell for quality and service in environmental monitoring
18 November 2015 | By Cherwell Laboratories
Cherwell publishes case study discussing key considerations when purchasing an active air sampler...
NICE says ‘no’ to Amgen’s Repatha in draft guidance
18 November 2015 | By Victoria White
The NICE Committee felt the question whether Repatha (evolocumab) would reduce angina, heart attacks and strokes remains unanswered...
FDA grants Breakthrough Therapy designation to avelumab for MCC
18 November 2015 | By Victoria White
Avelumab (MSB0010718C) is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody...
Personalised peptide vaccine increased bladder cancer survival in study
18 November 2015 | By Victoria White
The median overall survival for patients assigned personalised peptide vaccine and best-supportive care was almost twice as long as that for patients assigned best-supportive care...
Viking submits IND for VK2809 in hypercholesterolemia
18 November 2015 | By Victoria White
VK2809 is a novel, orally available small molecule thyroid receptor agonist that possesses selectivity for liver tissue as well as the beta receptor subtype...
Merck launches production of its anti-diabetes medicine in Algeria
18 November 2015 | By Victoria White
Merck and Novapharm have announced a joint venture in Algeria to produce Merck’s diabetes and high blood pressure treatments for the Algerian market...
Final call for innovators: Pharmapack Europe Awards 2016
17 November 2015 | By Victoria White
The Pharmapack Europe Awards centralise the latest innovations in packaging and drug delivery, offering a unique view into tomorrow’s developments today...
Global NSCLC treatment market value to rise to $10.9 billion
17 November 2015 | By Victoria White
GBI Research says that the introduction of novel immune-checkpoint inhibitors, such as Opdivo and Keytruda, will drive the market...
FDA approves Darzalex for multiple myeloma
17 November 2015 | By Victoria White
Darzalex (daratumumab) is the first human anti-CD38 monoclonal antibody (mAb) approved anywhere in the world...
Kadcyla ‘price remains too high’, says NICE
17 November 2015 | By Victoria White
NICE has published final draft guidance not recommending the use of Kadcyla as a treatment for a type of advanced breast cancer because the price is too high...
Futura provides update on efficacy study of MED2002
17 November 2015 | By Victoria White
MED2002 is the Company’s novel gel for the treatment of erectile dysfunction...
Novartis announces new trial results for Ultibro Breezhaler in COPD
17 November 2015 | By Victoria White
Once-daily Ultibro Breezhaler met its primary endpoint (non-inferiority) and also demonstrated superiority to twice-daily Seretide...
AbbVie releases new data on ABT-493 and ABT-530 in HCV
16 November 2015 | By Victoria White
The data show high rates of sustained virologic response at 12 weeks post-treatment in non-cirrhotic patients with chronic hepatitis C virus infection...
CI Precision announces new release of its MES
16 November 2015 | By CI Precision
CI Precision, global supplier of MES and weight sorting solutions, announces the release of version 6 of Ci-DMS, their manufacturing execution system (MES) which has gained established use in pharmaceuticals production...
